DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Anuh Pharma Limited — Change in Management

NSE 1 hr ago·14 Aug 2026, 6:03 pm

Anuh Pharma

Anuh Pharma Limited has announced a change in its top management, a development that the company has officially informed the stock exchanges about. This update signals a shift in the company's leadership structure, which is a routine corporate governance event but one that can sometimes alter the strategic direction of a firm.

For investors, this news is generally viewed as neutral in the short term. While leadership changes can bring fresh perspectives or operational shifts, they do not immediately impact the company's financial health or business performance. However, it is important to monitor how the new management plans to execute existing strategies.

Investors should keep an eye on future quarterly results and management commentary to understand if the new leadership is steering the company toward its long-term goals. Until then, the stock's performance is likely to remain driven by broader market trends rather than this specific corporate change.